S. Bioletto et al., Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects, AM J CLIN N, 71(2), 2000, pp. 443-449
Background: The influence of hyperinsulinemia on concentrations of lipoprot
ein subfractions in obese, nondiabetic persons has not been clarified.
Objective: We analyzed VLDL and LDL subfractions before and after a euglyce
mic, hyperinsulinemic clamp.
Design: Lipoprotein subfractions were isolated from plasma samples obtained
in the basal state and after a 4-h clamp from obese patients, obese patien
ts with type 2 diabetes, and nonobese control subjects.
Results: Hyperinsulinemia tended to reduce concentrations (x(over bar): 20%
) of large, triacylglycerol-rich VLDL, in obese patients but had a minor ef
fect on VLDL, and VLDL,. Placing obese patients into insulin-sensitive and
insulin-resistant subgroups revealed distinct effects of the degree of insu
lin sensitivity on VLDL. VLDL, concentrations decreased by a mean of 38% (P
< 0.05) in insulin-sensitive patients after the clamp, similar to but less
marked than the decrease observed in control subjects (x(over bar): 62%; P
< 0.01). VLDL, concentrations did not change significantly after the clamp
in insulin-resistant patients (and patients with type 2 diabetes), whereas
VLDL, concentrations decreased in both groups, in contrast with the change
s seen in the insulin-sensitive patients and control subjects. Acute hyperi
nsulinemia modified the LDL subfraction profile toward a greater prevalence
of small, dense LDLs in insulin-resistant patients and patients with type
2 diabetes.
Conclusions: Insulin resistance appears to be the primary determinant of th
e modifications to VLDL subfraction concentrations. Our results suggest a c
ontinuum of impaired insulin action on VLDL, ranging from that in healthy p
ersons to that in patients with type 2 diabetes, in which obese patients oc
cupy a transition state. Insulin resistance may also play a role in detrime
ntal modifications to the LDL profile by allowing the development of hypert
riglyceridemia.